Print
|
Note: The annual rebalancing of the Burrill Indices took place on October 1, 2013.
June 10, 2013
http://www.burrillreport.com/article-burrill_company_indices.html
BURRILL INDICES
Burrill & Company Indices
The Burrill Report
June 10, 2013
http://www.burrillreport.com/article-burrill_company_indices.html
June 10, 2013
http://www.burrillreport.com/article-burrill_company_indices.html
[Please login to post comments]
- Geisinger Allies with Genomics Researchers To Fight Liver Disease
Biopsy archive and sequencing power deliver results. Read More - Device Tax Foes Seize Opportunity in Budget Impasse
Bipartisan support exists for repeal, but only if it doesn't impede implementation of the Affordable Care Act. Read More - Big Data Comes to the Farm
Monsanto will pay $930 million for Climate Corp.’s weather-mining analytics and crop insurance services. Read More - Princess Di, Faked Moon Landings, and the Denial of Science
Study finds people who believe in conspiracy theories more likely to reject science. Read More - Intrexon Invests in Consumer-Focused “Living Art” Company
BioPop creates products using microorganisms for toys, novelty items, paintings. Read More - Wearable Health Tech Revenue Trends Toward $6B by 2018
Hot market is still fitness oriented, but lines are blurring as consumer demands evolve. Read More - Fate Therapeutics’ IPO Comes in Below Initial Target
Biotech slashes price, increases shares offered to raise $40.2M. Read More - Funding a Personalized Immunotherapy for MS
Podcast: October 7, 2013 Read More - What Winners Do to Beat the M&A; Odds
Podcast: October 2013 Read More - Lilly Still Plans on Meeting 2014 Goals
Company faces challenges, but is banking on new approvals and cost cutting. Read More
.gif)
